Tian V. Tian

1.1k total citations
27 papers, 572 citations indexed

About

Tian V. Tian is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tian V. Tian has authored 27 papers receiving a total of 572 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tian V. Tian's work include Pancreatic and Hepatic Oncology Research (6 papers), Prostate Cancer Treatment and Research (6 papers) and Pluripotent Stem Cells Research (5 papers). Tian V. Tian is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Prostate Cancer Treatment and Research (6 papers) and Pluripotent Stem Cells Research (5 papers). Tian V. Tian collaborates with scholars based in Spain, France and Palestinian Territory. Tian V. Tian's co-authors include Thomas Graf, Marta Gut, Grégoire Stik, Clara Berenguer, Ralph Stadhouders, Jinmi Choi, Martine Duterque‐Coquillaud, Patrick Cramer, Anne Flourens and Bruno Di Stefano and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tian V. Tian

23 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tian V. Tian Spain 12 434 82 76 74 68 27 572
Shujie He New Zealand 9 428 1.0× 86 1.0× 109 1.4× 87 1.2× 64 0.9× 17 539
Kunitoshi Chiba United States 10 546 1.3× 35 0.4× 119 1.6× 79 1.1× 70 1.0× 11 740
Wenbing Xie China 13 636 1.5× 39 0.5× 94 1.2× 109 1.5× 70 1.0× 19 739
Miguel Vizoso Spain 10 410 0.9× 52 0.6× 74 1.0× 113 1.5× 53 0.8× 15 499
Charles P. Xavier United States 8 292 0.7× 69 0.8× 71 0.9× 55 0.7× 40 0.6× 12 396
Siao‐Ping Tsai Taiwan 7 231 0.5× 62 0.8× 79 1.0× 85 1.1× 119 1.8× 9 528
Zongling Ji United Kingdom 12 491 1.1× 66 0.8× 117 1.5× 62 0.8× 52 0.8× 20 596
Ingegerd Elvers Sweden 11 578 1.3× 116 1.4× 132 1.7× 126 1.7× 115 1.7× 14 710
Zeynab Najafova Germany 13 637 1.5× 48 0.6× 177 2.3× 66 0.9× 60 0.9× 17 703
Asmin Tulpule United States 7 321 0.7× 62 0.8× 81 1.1× 51 0.7× 125 1.8× 9 474

Countries citing papers authored by Tian V. Tian

Since Specialization
Citations

This map shows the geographic impact of Tian V. Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian V. Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian V. Tian more than expected).

Fields of papers citing papers by Tian V. Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian V. Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian V. Tian. The network helps show where Tian V. Tian may publish in the future.

Co-authorship network of co-authors of Tian V. Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Tian V. Tian. A scholar is included among the top collaborators of Tian V. Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian V. Tian. Tian V. Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castet, Florian, et al.. (2025). Genomic profiling unlocks new treatment opportunities for ampullary carcinoma. ESMO Open. 10(5). 104480–104480.
2.
Lamarca, Ángela, et al.. (2025). From obscurity to opportunity: targeting Neuregulin 1 fusions in solid tumors. Signal Transduction and Targeted Therapy. 10(1). 194–194.
3.
Escudero, C. Iglesias, Tian V. Tian, Dmytro S. Radchenko, et al.. (2025). A bottom-up approach to find lead compounds in expansive chemical spaces. Communications Chemistry. 8(1). 225–225.
4.
Turpin, Anthony, et al.. (2025). Biliary tract cancers: addressing healthcare disparities and improving access to innovative treatments in Europe. The Lancet Regional Health - Europe. 50. 101215–101215. 1 indexed citations
5.
Vila-Casadesús, María, Tian V. Tian, Florian Castet, et al.. (2024). Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma During Targeted Therapy. Clinical Cancer Research. 30(19). 4491–4504. 13 indexed citations
6.
Arenas, Enrique J., Marta Escorihuela, Florian Castet, et al.. (2024). Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models. Methods in molecular biology. 2806. 139–151. 1 indexed citations
7.
Kowenz‐Leutz, Elisabeth, Tian V. Tian, Jonathan Lerner, et al.. (2023). Carm1-arginine methylation of the transcription factor C/EBPα regulates transdifferentiation velocity. eLife. 12. 1 indexed citations
8.
Castet, Florian, Vı́ctor Navarro, Daniel Acosta, et al.. (2023). Clinical and genomic characterisation of early-onset pancreatic cancer. European Journal of Cancer. 194. 113338–113338. 11 indexed citations
9.
Chiaravalli, Marta, Anthony Turpin, Florian Castet, et al.. (2023). Clinical and genomic characterization of pancreatic ductal adenocarcinoma patients with lung oligometastasis. SHILAP Revista de lepidopterología. 2. 100011–100011.
10.
Turpin, Anthony, Anne Flourens, Xavier Leroy, et al.. (2023). Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor. British Journal of Cancer. 129(12). 1903–1914. 3 indexed citations
11.
Stik, Grégoire, Carolina Segura-Morales, Noelia Alcázar, et al.. (2022). The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling. Stem Cell Reports. 17(9). 1991–2004. 9 indexed citations
12.
Tian, Tian V. & José Luis Sardina. (2021). Uncovering Sequence-Specific Transcription Factors Interacting with TET2. Methods in molecular biology. 2272. 239–250. 1 indexed citations
13.
Stik, Grégoire, Enrique Vidal, Sergi Cuartero, et al.. (2020). CTCF is dispensable for immune cell transdifferentiation but facilitates an acute inflammatory response. Nature Genetics. 52(7). 655–661. 91 indexed citations
14.
Tian, Tian V., Bruno Di Stefano, Grégoire Stik, et al.. (2019). Whsc1 links pluripotency exit with mesendoderm specification. Nature Cell Biology. 21(7). 824–834. 15 indexed citations
15.
Sardina, José Luis, Samuel Collombet, Tian V. Tian, et al.. (2018). Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate. Cell stem cell. 23(5). 727–741.e9. 165 indexed citations
16.
Pfisterer, Ulrich, Bruno Di Stefano, James Ashmore, et al.. (2017). Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular Reprogramming. Cell stem cell. 21(6). 791–805.e9. 23 indexed citations
17.
Giacomo, Viviana di, Tian V. Tian, Matteo Pecoraro, et al.. (2017). ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82. Oncogene. 36(31). 4381–4392. 17 indexed citations
18.
Flajollet, Sébastien, Tian V. Tian, Ludovic Huot, et al.. (2012). Increased Adipogenesis in Cultured Embryonic Chondrocytes and in Adult Bone Marrow of Dominant Negative Erg Transgenic Mice. PLoS ONE. 7(11). e48656–e48656. 6 indexed citations
19.
Flajollet, Sébastien, Tian V. Tian, Anne Flourens, et al.. (2011). Abnormal Expression of the ERG Transcription Factor in Prostate Cancer Cells Activates Osteopontin. Molecular Cancer Research. 9(7). 914–924. 27 indexed citations
20.
Tian, Tian V., et al.. (2009). Identification of four alternatively spliced transcripts of the Ucma/GRP gene, encoding a new Gla-containing protein. Experimental Cell Research. 316(2). 203–215. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shujie He Breakdown of academic impact, for papers by Kunitoshi Chiba Breakdown of academic impact, for papers by Wenbing Xie Breakdown of academic impact, for papers by Miguel Vizoso Breakdown of academic impact, for papers by Charles P. Xavier Breakdown of academic impact, for papers by Siao‐Ping Tsai Breakdown of academic impact, for papers by Zongling Ji Breakdown of academic impact, for papers by Ingegerd Elvers Breakdown of academic impact, for papers by Zeynab Najafova Breakdown of academic impact, for papers by Asmin Tulpule
Rankless by CCL
2026